101 related articles for article (PubMed ID: 29024931)
1. Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients.
Frega G; Garajová I; Palloni A; Barbera MA; Trossello Pastore M; Faccioli L; Spinardi L; De Lorenzo S; Cubelli M; Pantaleo MA; Biasco G; Brandi G
Oncology; 2018; 94(1):7-11. PubMed ID: 29024931
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era.
D'Andrea MR; Gill CM; Umphlett M; Tsankova NM; Fowkes M; Bederson JB; Brastianos PK; Shrivastava RK
Oncologist; 2020 May; 25(5):447-453. PubMed ID: 31694894
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases.
Tokoro T; Okuno K; Hida JC; Ueda K; Yoshifuji T; Daito K; Sugiura F
Clin Colorectal Cancer; 2014 Dec; 13(4):226-31. PubMed ID: 25442813
[TBL] [Abstract][Full Text] [Related]
4. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.
Dodoo GN; De B; Lee SS; Abi Jaoude J; Vauthey JN; Tzeng CD; Tran Cao HS; Katlowitz KA; Mandel JJ; Beckham TH; Minsky BD; Smith GL; Holliday EB; Koong AC; Das P; Taniguchi CM; Javle M; Koay EJ; Ludmir EB
Oncologist; 2023 Apr; 28(4):327-332. PubMed ID: 36715178
[TBL] [Abstract][Full Text] [Related]
5. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
[TBL] [Abstract][Full Text] [Related]
6. Patients with brain metastases from colorectal cancer are not condemned.
Mege D; Ouaissi M; Fuks D; Metellus P; Peltier J; Dufour H; Regimbeau JM; Dahan L; Sielezneff I; Sastre B
Anticancer Res; 2013 Dec; 33(12):5645-8. PubMed ID: 24324111
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
[TBL] [Abstract][Full Text] [Related]
8. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
[TBL] [Abstract][Full Text] [Related]
9. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.
Falkson SR; Bhambhvani HP; Hayden Gephart M
World Neurosurg; 2020 Aug; 140():e27-e32. PubMed ID: 32289508
[TBL] [Abstract][Full Text] [Related]
12. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
13. CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Noguchi K; Suzuki T; Nakamura T; Sato T; Ishigaki K; Hakuta R; Takeda T; Uchino R; Mizuno S; Kogure H; Tada M; Koike K
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1105-1112. PubMed ID: 29038848
[TBL] [Abstract][Full Text] [Related]
14. Trends in the incidence and management of biliary tract cancer: a French population-based study.
Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
Cho KM; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncologist; 2015 Aug; 20(8):926-33. PubMed ID: 26099746
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.
Flemming JA; Zhang-Salomons J; Nanji S; Booth CM
Cancer; 2016 Aug; 122(16):2534-43. PubMed ID: 27183133
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
[TBL] [Abstract][Full Text] [Related]
19. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer.
Tagawa T; Ito K; Fukuzawa K; Okamoto T; Yoshimura A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
Anticancer Res; 2017 Mar; 37(3):1413-1416. PubMed ID: 28314312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]